Overcoming barriers and achieving optimal implementation of cabotegravir and rilpivirine long-acting (CAB plus RPV LA): staff study participant (SSP) results from the CAB plus RPV Implementation Study in European Locations (CARISEL)

被引：0
|
作者：
Slama, L. [1 ]
Crusells-Canales, M. [2 ]
Olalla, J. [3 ]
DeMoor, R. [4 ]
Ait-Khaled, M. [5 ]
Dakhia, S. [6 ]
Van Mechelen, H. [7 ]
Hamilton, A. [8 ]
Hadi, M. [9 ]
Filipenko, D. [9 ]
Brown, F. [9 ]
Low, E. [9 ]
Gutner, C. [10 ]
Czarnogorski, M. [11 ]
机构：
[1] Assistance Publ Hop Paris AP HP, Hotel Dieu Hosp, Infect Dis Unit, Paris, France
[2] Hosp Clin Lozano Blesa, Infect Dis Serv, Zaragoza, Spain
[3] Costa Sol Hosp, Dept Internal Med, Marbella, Malaga, Spain
[4] GlaxoSmithKline, R&D Biostat, Collegeville, PA USA
[5] ViiV Healthcare Ltd, Clin Sci R&D, Brentford, England
[6] ViiV Healthcare Ltd, Med Affairs, Brentford, England
[7] ViiV Healthcare SRL, Med Affairs, Wavre, Belgium
[8] Univ Calif Los Angeles, Psychiat, Los Angeles, CA USA
[9] Evidera, Patient Ctr Res, London, England
[10] ViiV Healthcare Ltd, Global Med Sci Innovat & Implementat Sci, Durham, NC USA
[11] ViiV Healthcare, Global Med Sci, Durham, NC USA
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2022年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P116
引用
收藏
页码：111 / 112
页数：2
相关论文
共 20 条
  • [1] Implementation of cabotegravir and rilpivirine long-acting (CAB plus RPV LA): primary results from the CAB plus RPV Implementation Study in European Locations (CARISEL)
    Van Welzen, B.
    Vandekerckhove, L.
    Jonsson-Oldenbuettel, C.
    Hocqueloux, L.
    Ait-Khaled, M.
    Bontempo, G.
    DeMoor, R.
    Scherzer, J.
    D'Amico, R.
    Barnes, N.
    Hadi, M.
    Low, E.
    Anand, S.
    Czarnogorski, M.
    Gutner, C.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 71 - 72
  • [2] Perceptions of cabotegravir and rilpivirine long-acting (CAB plus RPV LA) from patients in the CAB plus RPV implementation study in European locations (CARISEL)
    Lutz, Thomas
    Jeanmaire, Eliette
    Portilla, Joaquin
    Scherzer, Jenny
    Trehan, Rekha
    Pascaul-Bernaldez, Miguel
    DeMoor, Rebecca
    Ait-Khaled, Mounir
    Hadi, Monica
    Anand, Savita Bakhshi
    Low, Emma L.
    Czarnogorski, Maggie
    Gutner, Cassidy A.
    Neumann, Jeanette
    [J]. HIV MEDICINE, 2023, 24 : 20 - 21
  • [3] Perceptions of cabotegravir and rilpivirine long-acting (CAB plus RPV LA) from patients in the CAB plus RPV Implementation Study in European Locations (CARISEL)
    Lutz, T.
    Jeanmaire, E.
    Portilla, J.
    Scherzer, J.
    Trehan, R.
    Pascual-Bernaldez, M.
    DeMoor, R.
    Ait-Khaled, M.
    Hadi, M.
    Anand, S.
    Low, E.
    Czarnogorski, M.
    Gutner, C.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2022, 25 : 117 - 118
  • [4] Perspectives on the acceptability, appropriateness, feasibility, barriers, and facilitators from patients receiving cabotegravir plus rilpivirine long-acting injectable treatment (CAB plus RPV LA): interim results from the Cabotegravir and Rilpivirine Implementation Study in European Locations (CARISEL)
    Hocqueloux, L.
    Gutner, C.
    DeMoor, R.
    Gill, M.
    Trehan, R.
    D'Amico, R.
    Tomkins, S.
    Schroeder, M.
    Bontempo, G.
    Ait-Khaled, M.
    Hadi, M.
    Anand, S. Bakhshi
    Low, E. L.
    Jeanmaire, E.
    Crusells Canales, M.
    Vandekerckhove, L.
    Bonnet, F.
    Olalla Sierra, J.
    Czarnogorski, M.
    [J]. HIV MEDICINE, 2021, 22 : 99 - 99
  • [5] Cabotegravir and Rilpivirine Implementation Study in European Locations (CARISEL): examining health care staff attitudes during a hybrid III implementation-effectiveness trial implementing cabotegravir plus rilpivirine long-acting injectable (CAB plus RPV LA) for people living with HIV (PLHIV)
    Gutner, C.
    Dakhia, S.
    Gill, M.
    Pascual-Bernaldez, M.
    Hernandez, B.
    Rami, A.
    Portilla, J.
    Lutz, T.
    van der Valk, M.
    Florence, E.
    Barnes, N.
    Cooper, O.
    Filipenko, D.
    Hamilton, A.
    Bosse, M.
    Czarnogorski, M.
    [J]. HIV MEDICINE, 2021, 22 : 114 - 115
  • [6] Patient Participant Perspectives on Implementation of Long-Acting Cabotegravir and Rilpivirine: Results From the Cabotegravir and Rilpivirine Implementation Study in European Locations (CARISEL) Study
    Gutner, Cassidy A.
    van der Valk, Marc
    Portilla, Joaquin
    Jeanmaire, Eliette
    Belkhir, Leila
    Lutz, Thomas
    Demoor, Rebecca
    Trehan, Rekha
    Scherzer, Jenny
    Pascual-Bernaldez, Miguel
    Ait-Khaled, Mounir
    Hernandez, Beatriz
    de Ruiter, Annemiek
    Anand, Savita Bakhshi
    Low, Emma L.
    Hadi, Monica
    Barnes, Nicola
    Sevdalis, Nick
    Mohammed, Perry
    Czarnogorski, Maggie
    [J]. JOURNAL OF THE INTERNATIONAL ASSOCIATION OF PROVIDERS OF AIDS CARE, 2024, 23
  • [7] Efficacy, safety and implementation outcomes of Cabotegravir plus Rilpivirine long-acting by country in the Cabotegravir and rilpivirine implementation study in European locations (CARISEL)
    Jonsson-Oldenbuettel, C.
    Ghosn, J.
    Sierra, J. Olalla
    van der Valk, M.
    Lutz, T.
    Belkhir, L.
    van Welzen, B. J.
    Hove, K.
    Ait-Khaled, M.
    DeMoor, R.
    Bontempo, G.
    Latham, C. L.
    Ngenzi, B.
    Okoli, C.
    Gutner, C. A.
    Iyer, S.
    Gill, M.
    Czarnogorski, M.
    D'Amico, R.
    van Wyk, J.
    [J]. HIV MEDICINE, 2023, 24 : 193 - 195
  • [8] The use and utility of toolkits in supporting cabotegravir plus rilpivirine long-acting implementation in the CARISEL (Cabotegravir And Rilpivirine Implementation Study in European Locations) study
    Trehan, Rekha
    Gutner, Cassidy
    Okoli, Chinyere
    Ghosn, Jade
    Vera, Francisco
    Florence, Eric
    Lutz, Thomas
    van der Valk, Marc
    Czarnogorski, Maggie
    [J]. HIV MEDICINE, 2023, 24 : 93 - 93
  • [9] Top practices for implementing cabotegravir (CAB) and rilpivirine (RPV) long-acting (LA) in European clinics
    Olalla, Julian
    Gutner, Cassidy
    Pascual-Bernaldez, Miguel
    Hernandez, Beatriz
    Dakhia, Samia
    Slama, Laurence
    Crusells Canales, Maria Jose
    Lutz, Thomas
    van der Valk, Mark
    van Welzen, Berend
    Florence, Eric
    Barnes, Nicola
    Cooper, Owen
    Filipenko, Dina
    Czarnogorski, Maggie
    [J]. HIV MEDICINE, 2022, 23 : 27 - 28
  • [10] Initiation of cabotegravir and rilpivirine long-acting (CAB plus RPV LA) regimen across five European countries in CARISEL during the COVID-19 pandemic
    Czarnogorski, Maggie
    Wang, Yongwei
    Tomkins, Ms. Susan
    Yu, Ren
    Barnes, Nicola
    Patel, Parul
    Gill, Martin
    Ait-Khaled, Mounir
    Gutner, Cassidy
    Moorhouse, Michelle
    D'Amico, Ronald
    Bosse, Matthew
    [J]. HIV MEDICINE, 2021, 22 : 5 - 6
12